Polaris AI Pharma Corp. (KOSDAQ:041910)
South Korea · Delayed Price · Currency is KRW 5,460.00
-20.00 (-0.36%)
At close: Sep 11, 2026
Polaris AI Pharma Market Cap
Polaris AI Pharma has a market cap or net worth of 72.53 billion as of September 11, 2026. Its market cap has decreased by -16.00% in one year.
Market Cap
72.53B
Enterprise Value
n/a
Revenue
63.94B
Ranking
n/a
PE Ratio
64.45
Stock Price
5,460.00
ChartMarket Cap Chart
Since May 17, 2004, Polaris AI Pharma's market cap has increased from 10.75B to 72.53B, an increase of 574.67%. That is a compound annual growth rate of 8.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 72.53B | -12.36% |
| Dec 30, 2025 | 82.76B | 16.23% |
| Dec 30, 2024 | 71.20B | -11.66% |
| Dec 28, 2023 | 80.59B | -2.68% |
| Dec 29, 2022 | 82.81B | -26.15% |
| Dec 30, 2021 | 112.13B | -24.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sam-A Pharm. | 85.14B |
| KOREA PHARMA | 83.11B |
| Samik Pharmaceutical Company LTD. | 79.63B |
| Daehan Nupharm | 78.46B |
| BL Pharmtech | 75.91B |
| GL Pharm Tech | 72.59B |
| Pharos iBio | 71.85B |
| Optipharm.CO.,LTD | 69.83B |